Netilmicin in Gram-Negative Bacterial Infections
Netilmicin, a new semisynthetic aminoglycoside, was used in the treatment of 42 patients with serious gram-negative bacterial infections. Of the 40 evaluable patients, 24 (60%) were cured, and 8 (20%) had a favorable clinical response, for a total clinical response rate of 80%. Eight patients failed...
Bewaard in:
| Gepubliceerd in: | Antimicrob Agents Chemother |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology (ASM)
1979
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352599/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/426506/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.15.1.50 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|